Literature DB >> 20519276

Long-term histological follow-up of people with coeliac disease in a UK teaching hospital.

J M Hutchinson1, N P West, G G Robins, P D Howdle.   

Abstract

BACKGROUND: Coeliac disease is a relatively common condition which is usually managed by placing patients on a gluten free diet. Follow up biopsies to confirm histological recovery are controversial with a considerable variation in practice observed. AIM: To determine the length of time to histopathological recovery in a group of coeliac disease patients and its associations with clinicopathological data. DESIGN AND METHODS: All patients attending a specialist coeliac disease clinic prior to March 2009 were entered onto a database which recorded various clinicopathological data. The histopathology reports for all duodenal biopsies were reviewed and each biopsy was given a histopathological disease score based on a modified Marsh grade.
RESULTS: Two hundred and eighty-four patients underwent index and at least one subsequent biopsy. Two-hundred and twenty-seven (80%) showed histopathological improvement and 100 (35%) returned to normal (median recovery time 1.9 years, inter-quartile range 1.0-4.8 years). Patients with less severe disease at diagnosis were more likely to show a better response (r = 0.281, P < 0.0001). Older patients demonstrated a shorter time to histopathological recovery (r = -0.200, P = 0.001). Compliance with a gluten free diet was correlated with the best biopsy score (r = -0.134, P = 0.040) and degree of histological recovery (r = 0.161, P = 0.014).
CONCLUSION: Current guidelines for the timing of repeat biopsy after commencing a gluten free diet are unclear, although 4-6 months has been recommended. This study shows that time to histological recovery is longer than traditionally thought and may need to take into account the patient's age at diagnosis, the initial disease score and the level of compliance with a gluten free diet.

Entities:  

Mesh:

Year:  2010        PMID: 20519276     DOI: 10.1093/qjmed/hcq076

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  20 in total

1.  Persistence of elevated deamidated gliadin peptide antibodies on a gluten-free diet indicates nonresponsive coeliac disease.

Authors:  B N Spatola; K Kaukinen; P Collin; M Mäki; M F Kagnoff; P S Daugherty
Journal:  Aliment Pharmacol Ther       Date:  2014-01-06       Impact factor: 8.171

2.  Predictors and Significance of Incomplete Mucosal Recovery in Celiac Disease After 1 Year on a Gluten-Free Diet.

Authors:  Henna Pekki; Kalle Kurppa; Markku Mäki; Heini Huhtala; Harri Sievänen; Kaija Laurila; Pekka Collin; Katri Kaukinen
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

Review 3.  Practical insights into gluten-free diets.

Authors:  Jacalyn A See; Katri Kaukinen; Govind K Makharia; Peter R Gibson; Joseph A Murray
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-22       Impact factor: 46.802

Review 4.  Support for patients with celiac disease: A literature review.

Authors:  Jonas F Ludvigsson; Tim Card; Paul J Ciclitira; Gillian L Swift; Ikram Nasr; David S Sanders; Carolina Ciacci
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

5.  Intraepithelial lymphocyte immunophenotype: a useful tool in the diagnosis of celiac disease.

Authors:  Rebeca Saborido; Nazareth Martinón; Alexandra Regueiro; Vanesa Crujeiras; Pablo Eiras; Rosaura Leis
Journal:  J Physiol Biochem       Date:  2017-08-16       Impact factor: 4.158

6.  Persistent mucosal damage and risk of fracture in celiac disease.

Authors:  Benjamin Lebwohl; Karl Michaëlsson; Peter H R Green; Jonas F Ludvigsson
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

7.  Predictors of persistent villous atrophy in coeliac disease: a population-based study.

Authors:  B Lebwohl; J A Murray; A Rubio-Tapia; P H R Green; J F Ludvigsson
Journal:  Aliment Pharmacol Ther       Date:  2014-01-16       Impact factor: 8.171

8.  All that glitters is not always gold.

Authors:  E Harrison; S Hayes; L Howell; S Lal
Journal:  BMJ Case Rep       Date:  2014-02-10

9.  The management of refractory coeliac disease.

Authors:  Jeremy Woodward
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

10.  Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study.

Authors:  Benjamin Lebwohl; Fredrik Granath; Anders Ekbom; Karin E Smedby; Joseph A Murray; Alfred I Neugut; Peter H R Green; Jonas F Ludvigsson
Journal:  Ann Intern Med       Date:  2013-08-06       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.